Pipeline
FibroSIS Pipeline
We are working to advance treatment options and reset the current standard of care for patients with Dupuytren’s disease, Ledderhose disease, and related fibrotic diseases. Our investigational pipeline includes two small molecules with different mechanisms of action.
The investigational products listed on this page are not approved by the FDA or have not been approved for the above referenced indication, and the safety and effectiveness of such has not been established.